Search for: "SYSTEM GENERAL CORP V ITC" Results 221 - 234 of 234
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will… [read post]
7 Mar 2008, 2:00 am
: (Dilanchian), Review of National Innovation System: (IP Menu News) Bahrain Bahrain gives itself longer to refuse Madrid marks: (I [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
15 Feb 2008, 9:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]Highlights this week included:EU wants 95 year copyright on recordings: (IPKat), (Ars Technica), (Intellectual Property Watch), (IP Law360),Harvard Arts and Sciences Faculty decides to allow open access to research: (Techdirt), (Michael Geist), (Ars Technica), (Against Monopoly),Summary judgment hearing 8 Feb: Tafas & GSK v Dudas concerning implementation of the USPTO’s new… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
8 Dec 2007, 11:00 am
(more on the Wahaha v Danone dispute): (China Business Law Blog), What Global Players could learn from Wii v Vii [Nintendo's global new product launch mistakes]: (IPDragon), (China Law Blog), Junk Patents: (China Hearsay),Has your distributor (representative, manufacturer) in China registered your mark? [read post]
23 Nov 2007, 9:00 am
Astra's Data Exclusivity prevents a European generic launch, until at least 2010.: (Generic Pharmaceuticals & IP), Iressa (gefitinib) - Astrazeneca's Indian patent application rejected: (Generic Pharmaceuticals & IP), Ziagen (Abacavir Hemisulfate Salt) -GSK's application [872/CAL/98; corresponding to Orange Book listed US6294540] opposed by Indian Network for People living with HIV/ AIDS and then withdrawn by GSK: (Generic… [read post]